Rockwell Medical (RMTI) Gains on China Nod

Rockwell Medical Inc RMTI shares gained 1.5% to $6.16 after the company reported that the China FDA has accepted its Triferic drug submission for commercialization in China. Share volume was 77,000, compared to an all-day average of 146,000